Aphria completes sale of interests in Copperstate Farms

WORKFLOW SOLUTIONS
PRODUCTS
See More S&P Global Solutions
CONTENT
PODCASTS
SEE ALL EPISODES
SECTOR-SPECIFIC INSIGHTS
More ways we can help
NEWS & RESEARCH TOPICS
See More
Featured Events
Webinar2024 Regulatory Reporting Horizon: what to expect and how to prepare
- 12/05/2023
- Live, Online
- 03:00 pm - 04:00 pm GMT | 10:00 am- 11:00 am EST
WebinarUnderstanding, Identifying, and Assessing Supplier Diversity
- 12/06/2023
- Live, Online
- 01:00 pm - 02:00 pm EST
Webinar2024 Regulatory Reporting Horizon: what to expect and how to prepare
- 12/05/2023
- Live, Online
- 03:00 pm - 04:00 pm GMT | 10:00 am- 11:00 am EST
PLATFORMS
OTHER PRODUCTS
- Research Online
- 451 Research
See All Product Logins

In This List

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises

5 Jul, 2018 | 11:28

Author Mark Louie Bonayon
Theme Healthcare & Pharmaceuticals

Aphria Inc. completed the sale of its stake in Copperstate Farms LLC and Copperstate Farms Investors LLC.

In February, Liberty Health Sciences Inc. said it is acquiring Aphria (Arizona) Inc. and Aphria's minority stakes in Copperstate Farms and Copperstate Farms Investors for $20 million.

Canadian medical cannabis company Aphria said it realized a gain of about $8.8 million on the sale.